Interestingly, survivors from the group treated with CTX and anti-PDL1 + PDL2 Abs displayed higher tumor-specific reactivity as compared to mice treated with CTX + anti-PDL1 Ab (Supplementary Materials Figure S1A). Here, PDCD1LG2 is linked to neoplasm.